Whitehawk Therapeutics (WHWK) Revenue & Revenue Breakdown
Whitehawk Therapeutics Revenue Highlights
Latest Revenue (Y)
$25.98M
Latest Revenue (Q)
$7.24M
Whitehawk Therapeutics Revenue by Period
Whitehawk Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $25.98M | 6.69% |
| 2023-12-31 | $24.35M | 60.06% |
| 2022-12-31 | $15.22M | 1258.57% |
| 2021-12-31 | $1.12M | -92.32% |
| 2020-12-31 | $14.58M | - |
Whitehawk Therapeutics generated $25.98M in revenue during NA 2024, up 6.69% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Whitehawk Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $7.24M | 0.37% |
| 2024-09-30 | $7.21M | 16.72% |
| 2024-06-30 | $6.18M | 15.43% |
| 2024-03-31 | $5.35M | -15.38% |
| 2023-12-31 | $6.33M | 6.16% |
| 2023-09-30 | $5.96M | -3.92% |
| 2023-06-30 | $6.20M | - |
Whitehawk Therapeutics generated $7.24M in revenue during Q4 2024, up 0.37% compared to the previous quarter, and up 121.48% compared to the same period a year ago.
Whitehawk Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| CNTB | Connect Biopharma | $26.03M | $1.91M |
| WHWK | Whitehawk Therapeutics | $25.98M | $7.24M |
| SPRB | Spruce Biosciences | $4.91M | - |
| ORMP | Oramed Pharmaceuticals | $1.34M | - |
| ADVM | Adverum Bio | $1.00M | - |
| ATYR | aTyr Pharma | $353.00K | - |
| GUTS | Fractyl Health | $120.00K | - |
| QNCX | Quince Therapeutics | - | - |
| KLRS | Kalaris Therapeutics | - | - |
| PLRX | Pliant Therapeutics | - | - |
| BMEA | Biomea Fusion | - | - |